Gammagard Lawsuits

The Dangers Of Gammagard, And What It Could Mean For You!

Gammagard (immune globulin) is an intravenous solution that is made from human plasma. It is a sterile solution, which is comprised of antibodies that are necessary to maintain immunity and fight disease. It also helps the body fight various infections and stay healthy.

Due to Gammagard side effects there have been Gammagard lawsuits, because the drug has not performed, as it should in some people. The Gammagard lawsuits came in part from people who became infected with Hepatitis C while taking Gammagard.

The use of Gammagard can lead to:

• Urinating less than usual or not at all
• Weight gain, swelling
• Shortness of breath
• Vomiting, fever, or headache
• Pale or yellow colored skin
• Dark urine

Because of the high number of incidences involving patients who were taking Gammagard becoming infected with Hepatitis C or Hep C, a Gammagard class action lawsuit was launched. People who were taking Gammagard noticed that they were having symptoms associated with Hepatitis C and when they got tested for the virus their tests came back positive.

 

AttorneyOne.com is a free nationwide legal referral service. We are not a law firm. We help consumers find the best representation for their legal needs.

If you or a loved one are in need of legal assistance concerning Gammagard you should get a lawyer on your side immediately. You will pay no attorney fees unless you win your case.

Email up to 10 Gammagard law firms in one click; by filling out the simple Free Case Evaluation form.

For additional info on Gammagard use the practice area links on the far right.

Twitter Digg Delicious Stumbleupon Technorati Facebook Email
  • Comments:

    When authoring your comments please try to include the Who? What? Where? When? and How?

    The more information our attorneys have the better they can evaluate your potential claim.

This post is written by

Trackbacks/Pingbacks

  1. AttorneyOne.com Informs: You Can Still File a Claim and Receive Compensation for Gammagard Side Effects | Blog Interact Press Releases - 11-Feb-2012

    [...] law, can provide helpful, proven advice and simple solutions including how to get in contact with legal council so anyone can easily and inexpensively deal with cases of Gammagard side [...]

  2. bestheartattacktreatment.com » Blog Archive » Baxter submits Application for FDA Approval of Gammagard Liquid – AttorneyOne.com informs: you can still file a claim and receive compensation for Gammagard side effects - 12-Mar-2012

    [...] legal counsel so anyone can easily and inexpensively deal with cases of Gammagard side effects [http://www.attorneyone.com/gammagard-lawsuits/ [...]

  3. bestheartattacktreatment.com » Blog Archive » Baxter Recalls Gammagard Liquid 10%, 20g: You Can Still File a Claim for Gammagard Adverse Events - 06-Apr-2012

    [...] On March 14th, 2012 Baxter announced the voluntary recall of specific Lot of Gammagard Liquid [Immune Globulin Intravenous (Human)] 10%, 20g size as a precautionary measure due to a labeling error noted on the product vial label and unit carton. Gammagard, manufactured by Baxter, is an intravenous solution that is made from human plasma. It is a sterile solution, which helps the body to maintain immunity and fight disease. In February 1994, Baxter announced it was removing Gammagard from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Gammagard severe adverse events (http://www.attorneyone.com/gammagard-lawsuits). [...]

  4. bestheartattacktreatment.com » Blog Archive » Baxter Presents Positive Data on Gammagard: Severe Adverse Events - 18-May-2012

    [...] On April 27th, 2012, Baxter, the company manufacturing Gammagard, announced positive Phase III clinical data of Gammagard Liquid 10% [Immune Globulin Intravenous (Human)], used for treating multifocal motor neuropathy (MMN). Gammagard is an intravenous solution that is made from human plasma. It is a sterile solution, which helps the body maintain immunity and fight disease. In February 1994, Baxter announced it was removing Gammagard from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Gammagard severe adverse events. http://www.attorneyone.com/gammagard-lawsuits/ [...]

  5. Gammagard Approved for Multifocal Motor Neuropathy: Severe Adverse Events | Apple - 26-Jun-2012

    [...] counsel so anyone can easily and inexpensively deal with cases of Gammagard severe adverse events. http://www.attorneyone.com/gammagard-lawsuits/. Click here to view more details Buy a Dyson 10 Table Fan White, Get a Free $60 Target Gift [...]

  6. New Study on Stabilization of Alzheimer’s with Gammagard: Severe... - HCI Market - 24-Jul-2012

    [...] media spotlight is often a double-edged sword. No one knows this better than people who suffer from Gammagard Side Effects. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to [...]

  7. New Study on Stabilization of Alzheimer’s with Gammagard: Severe Adverse Events | Apple - 24-Jul-2012

    [...] New Study on Stabilization of Alzheimer’s with Gammagard: Severe Adverse Events July 24, 2012 A new study presented on July 17th, 2012, at the Alzheimer's Association International Conference 2012 in Vancouver revealed Alzheimer's disease symptoms long-term (three-year) stabilization with Gammagard. Gammagard, manufactured by Baxter, is an intravenous solution that is made from human plasma (intravenous immunoglobulin, or IVIG). It is a sterile solution, which helps the body maintain immunity and fight disease. In February 1994, Gammagard was pulled off from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Gammagard severe adverse events. [http://www.attorneyone.com/gammagard-lawsuits/ [...]

  8. Baxter Announces Discontinuation of Gammagard S/D - HCI Market - 23-Aug-2012

    [...] media spotlight is often a double-edged sword. No one knows this better than people who filed a Gammagard Recall lawsuit. And yet, gossip and rumor-mongering aside, the real story here is being overlooked [...]

  9. Experimental Alzheimer’s Drug Shows Some Potential: Threat from Gammagard Remains - 24-Sep-2012

    [...] On August 24th, 2012 BusinessWeek reported that Elli Lilly’s experimental new drug for the treatment of Alzheimer’s disease delayed the worsening of mental loss, in a sub-analysis of patients in the earliest stage of the disease, while failing to meet the primary goals of two large trials. The only other therapy in final-stage testing is Baxter International Inc.’s Gammagard, an intravenous solution that is made from human plasma. At the end of February 1994, Baxter announced it was removing Gammagard from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Gammagard severe adverse events. [http://www.attorneyone.com/gammagard-lawsuits/ [...]

  10. Gammagard Problematic for Success in Mild-to-Moderate Alzheimer’s: Now, AttorneyOne Can Provide Advice for Legal Counsel in Cases of Side Effects | Apple - 24-Jan-2013

    [...] Gammagard Problematic for Success in Mild-to-Moderate Alzheimer’s: Now, AttorneyOne Can Provide Advice for Legal Counsel in Cases of Side Effects January 24, 2013 On January 22nd 2013, the Financial Times published that Phase III Gammagard clinical trial has been met with reservation from experts, who cited the mild-to-moderate patient population as problematic for success in treating Alzheimer’s disease. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Gammagard side effects. http://www.attorneyone.com/gammagard-lawsuits/ [...]

A wordpress install assisted by technofreak